Page last updated: 2024-09-05

ilaprazole and Chronic Disease

ilaprazole has been researched along with Chronic Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jin, Y; Pan, J; Wang, Q; Yao, D; Yue, M; Zhang, G; Zhang, S1
Chen, MZ; Cong, YY; Huang, XP; Huang, YY; Liao, XM; Nong, GH; Wei, JQ; Wu, BH1

Trials

2 trial(s) available for ilaprazole and Chronic Disease

ArticleYear
Comparison of efficacy and safety of ilaprazole and esomeprazole both in initial treatment regimen and retreatment regimen of Helicobacter pylori infection in chronic gastritis.
    Die Pharmazie, 2019, 07-01, Volume: 74, Issue:7

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Chronic Disease; Drug Therapy, Combination; Esomeprazole; Female; Furazolidone; Gastritis; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Minocycline; Prospective Studies; Proton Pump Inhibitors; Retreatment; Treatment Failure; Treatment Outcome

2019
Modified sequential therapy vs quadruple therapy as initial therapy in patients with Helicobacter infection.
    World journal of gastroenterology, 2015, May-28, Volume: 21, Issue:20

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; China; Chronic Disease; Clavulanic Acid; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Middle Aged; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Time Factors; Treatment Outcome

2015